Table 3.
Comparison | Univariable model | Multivariable modele | Multivariable modelf | |||||||
---|---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | HR | 95% CI | P | ||
PTC | TC-BC vs TCnoBC | 0.472 | 0.370-0.601 | <.001a | 0.477 | 0.375-0.608 | <.001a | 0.529 | 0.415-0.675 | <.001a |
TC-1st vs TCnoBC | 0.397 | 0.268-0.588 | <.001a | 0.399 | 0.270-0.591 | <.001a | 0.409 | 0.276-0.607 | <.001a | |
BC-1st vs TCnoBC | 0.607 | 0.445-0.827 | .002b | 0.625 | 0.458-0.852 | <.001b | 0.797 | 0.584-1.088 | .153 | |
FTC | TC-BC vs TCnoBC | 0.656 | 0.461-0.934 | .019c | 0.648 | 0.455-0.922 | .016c | 0.799 | 0.560-1.140 | .215 |
TC-1st vs TCnoBC | 0.458 | 0.259-0.810 | .007b | 0.448 | 0.253-0.792 | .006b | 0.568 | 0.319-1.011 | .054d | |
BC-1st vs TCnoBC | 0.926 | 0.588-1.459 | .741 | 0.940 | 0.597-1.480 | .789 | 1.262 | 0.795-2.003 | .324 |
Abbreviations: BC, breast cancer; BC-1st, TC patients diagnosed after BC; CI, confidence interval; FTC, follicular TC; HR, hazard ratio; PTC, papillary TC; SEER, Surveillance, Epidemiology and End Results; SES, socioeconomic status; TC, thyroid cancer; TC-1st, TC patients diagnosed before BC; TCnoBC, TC patients without history of BC.
aP less than .001; bP less than .01; cP less than .05; dP less than .1.
e Multivariable model adjusted by SES factors including race, medical insurance, education levels.
f Multivariable model adjusted by SES factors including race, medical insurance, and education levels and clinicopathological characteristics including SEER stage, tumor size, and distant metastasis and extension.